[1]Locationinpatent:experimentalpartBridger,GaryJ.;Skerlj,RenatoT.;Hernandez-Abad,PedroE.;Bogucki,DavidE.;Wang,Zhongren;Zhou,Yuanxi;Nan,Susan;Boehringer,EvaM.;Wilson,Trevor;Crawford,Jason;Metz,Markus;Hatse,Sigrid;Princen,Katrien;DeClercq,Erik;Schols,Dominique[JournalofMedicinalChemistry,2010,vol.53,#3,p.1250-1260]
[1]Zhang,Xuran;You,Linyi;Chen,Shuting;Gao,Mengna;Guo,Zhide;Du,Jin;Lu,Jie;Zhang,Xianzhong[Journaloflabelledcompoundsandradiopharmaceuticals,2018,vol.61,#5,p.438-446]
Title: Stromal cell-derived factor 1α mediates resistance to mTOR-directed therapy in pancreatic cancer.
Journal: Neoplasia (New York, N.Y.) 20120801
Title: Enhancement of the anti-tumor activity of therapeutic monoclonal antibodies by CXCR4 antagonists.
Journal: Leukemia & lymphoma 20120101
Title: CXCR4 antagonism attenuates the cardiorenal consequences of mineralocorticoid excess.
Journal: Circulation. Heart failure 20110901
Title: Imaging CXCR4 expression in human cancer xenografts: evaluation of monocyclam 64Cu-AMD3465.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20110601
Title: Importance of receptor flexibility in binding of cyclam compounds to the chemokine receptor CXCR4.
Journal: Journal of chemical information and modeling 20110124
Title: Synthesis and structure-activity relationships of azamacrocyclic C-X-C chemokine receptor 4 antagonists: analogues containing a single azamacrocyclic ring are potent inhibitors of T-cell tropic (X4) HIV-1 replication.
Journal: Journal of medicinal chemistry 20100211
Title: Pharmacology of AMD3465: a small molecule antagonist of the chemokine receptor CXCR4.
Journal: Biochemical pharmacology 20091015
Title: Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML.
Journal: Blood 20090611
Title: Comparison of the potential multiple binding modes of bicyclam, monocylam, and noncyclam small-molecule CXC chemokine receptor 4 inhibitors.
Journal: Molecular pharmacology 20081201
Title: Molecular mechanism of action of monocyclam versus bicyclam non-peptide antagonists in the CXCR4 chemokine receptor.
Journal: The Journal of biological chemistry 20070914
Title: Entry inhibitor-based microbicides are active in vitro against HIV-1 isolates from multiple genetic subtypes.
Journal: Virology 20070801
Title: AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor.
Journal: Biochemical pharmacology 20050901
Title: Hatse S, et al. AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor. Biochem Pharmacol. 2005 Sep 1;70(5):752-61.
Title: Yang L, et al. Blocking CXCR4-mediated cyclic AMP suppression inhibits brain tumor growth in vivo. Cancer Res. 2007 Jan 15;67(2):651-8.
